Salarius Pharmaceuticals, Inc.
SLRX
$0.698
-$0.0348-4.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.74% | -56.68% | -71.64% | -52.84% | -51.27% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -46.52% | -27.53% | -15.34% | -14.82% | -22.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -54.18% | -54.08% | -70.61% | -51.41% | -55.10% |
|
|
|||||
| Total Current Assets | -54.18% | -54.08% | -70.61% | -51.41% | -55.10% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -47.09% | -54.60% | -59.70% | -53.52% | -48.74% |
| Total Assets | -54.10% | -54.08% | -70.52% | -51.43% | -55.04% |
|
|
|||||
| Total Accounts Payable | 55.42% | -84.77% | -71.88% | -79.66% | -78.91% |
| Total Accrued Expenses | -13.35% | -43.08% | -60.47% | -59.07% | -71.11% |
| Short-term Debt | -23.38% | -28.38% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.33% | -59.72% | -67.64% | -72.55% | -69.55% |
|
|
|||||
| Total Current Liabilities | 16.33% | -59.72% | -67.64% | -72.55% | -69.55% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -23.38% | -28.38% | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 16.33% | -59.72% | -67.64% | -72.55% | -69.55% |
|
|
|||||
| Common Stock & APIC | 2.21% | 2.25% | 0.52% | 9.38% | 10.04% |
| Retained Earnings | -7.30% | -6.62% | -8.85% | -12.90% | -19.66% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -71.41% | -51.93% | -71.77% | -34.35% | -49.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -71.41% | -51.93% | -71.77% | -34.35% | -49.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -71.41% | -51.93% | -71.77% | -34.35% | -49.09% |
|
|
|||||